Deliverables

Key deliverables and the expected delivery date.

Some deliverables are initially confidential, but an executive summary will be made available immediately. The deliverable will become available on the website after the use of data for scientific publication(s).

Outputs

Development or adjustment of tailored interventions

  • D3.1: A report with an assessment of the likelihood of successful transfer of vaccine uptake promoting interventions, naming barriers and facilitators for transfer; including indications and recommendations for adaptations of the interventions to better fit the target context and a successful implementation therein.
    Expected Delivery: Fourth quarter of 2022
  • D3.2: A selection of health system barriers to be addressed will be made for each of the five underserved communities.
    Expected Delivery: Third quarter of 2022
  • D3.3: A matrix per intervention will be developed, containing intervention objectives, including the barriers and facilitators to be influenced.
    Expected Delivery: First quarter of 2023
  • D3.4: A provisional list of potential methods and strategies for intervention implementation based on experts’ input, consultation of target communities and the literature review.
    Expected Delivery: Third quarter of 2023
  • D3.5: Development of coherent interventions
    Expected Delivery: Third quarter of 2023

Some deliverables are initially confidential, but an executive summary will be made available immediately. The deliverable will become available on the website after the use of data for scientific publication(s).

WP3 Leader: Academisch Ziekenhuis Groningen (UMCG), the Netherlands

WP3 Co-Leader (Tasks 3.1, 3.2): Maastricht University

Implementation and Evaluation of tailored interventions:

  • D4.1: Preparation of the implementation plans including monitoring and evaluation frameworks (1 for each intervention)
    Expected Delivery: Fourth quarter of 2023
  • D4.2: Implementation reports including monitoring/evaluation results (quantitative, qualitative and cost effectiveness), one for each community where the intervention is implemented.
    Expected Delivery: Fourth quarter of 2025
  • D4.3: Overall report presenting key findings from individual implementations.
    Expected Delivery: First quarter of 2026

Some deliverables are initially confidential, but an executive summary will be made available immediately. The deliverable will become available on the website after the use of data for scientific publication(s).

WP3 Leader: Astiki Mikerdoskopiki Etaireia Prolipsis (Prolepsis), Greece

WP4 Co-Leader (Task 4.3.2):Academisch Ziekenhuis Groningen (UMCG), the Netherlands

Guideline development 

  • D5.1: The creation of guidelines that will be applicable to all EU countries and will enable them to remove health systems barriers to immunisation among underserved communities.
    Expected Delivery: First quarter of 2026

The guidelines will be accompanied by:

  • D5.2: Action framework applicable to all three levels targeted by the guidelines (national, subnational and facility) to ensure that they are implementable and relevant to the operational level in each country
    Expected Delivery: First quarter of 2026
  • D5.3: Interactive tool - an online version of the guidelines and action framework
    Expected Delivery: First quarter of 2026

Some deliverables are initially confidential, but an executive summary will be made available immediately. The deliverable will become available on the website after the use of data for scientific publication(s).

WP5 Leader:UK Health Security Agency (UKHSA)

Strengthening Education and Knowledge on Immunisation (SEKI)

  • D6.1: Establishment of an online system with up-to-date educational content for healthcare workers and medical students, which presents the possibility to register for educational activities and to collect training points once the platform has passed the testing phase.
    Expected Delivery: Third quarter of 2023
  • D6.2: Report based on lessons learned in RIVER-EU and exclusive Strengthening Education and Knowledge on Immunisation (SEKI) training materials dedicated to cultural competency working on migrant and minority health, as well as online platform sustainability.
    Expected Delivery: Second quarter of 2026

Some deliverables are initially confidential, but an executive summary will be made available immediately. The deliverable will become available on the website after the use of data for scientific publication(s).

WP6 Leader: Vienna Vaccine Safety Initiative (VIVI)

Dissemination and exploitation

  • D7.1: Dissemination and Communication Plan and visual identity, and website launch.
    Expected Delivery: Third quarter of 2021
  • D7.2: A report on the engagement of target groups will be produced in M24, to assess the need for changes in strategy.
    Expected Delivery: Second quarter of 2023
  • D7.3: Exploitation plan.
    Expected Delivery: Second quarter of 2025

Some deliverables are initially confidential, but an executive summary will be made available immediately. The deliverable will become available on the website after the use of data for scientific publication(s).

WP7 Leader: EuroHealthNet

WP7 Co-Lead: Connaxis

Project timeline

Development or adjustment of tailored interventions

  • D3.1: A report with an assessment of the likelihood of successful transfer of vaccine uptake promoting interventions, naming barriers and facilitators for transfer; including indications and recommendations for adaptations of the interventions to better fit the target context and a successful implementation therein.
    Expected Delivery: Fourth quarter of 2022
  • D3.2: A selection of health system barriers to be addressed will be made for each of the five underserved communities.
    Expected Delivery: Third quarter of 2022
  • D3.3: A matrix per intervention will be developed, containing intervention objectives, including the barriers and facilitators to be influenced.
    Expected Delivery: First quarter of 2023
  • D3.4: A provisional list of potential methods and strategies for intervention implementation based on experts’ input, consultation of target communities and the literature review.
    Expected Delivery: Third quarter of 2023
  • D 3.5: Development of coherent interventions
    Expected Delivery: Third quarter of 2023

Some deliverables are initially confidential, but an executive summary will be made available immediately. The deliverable will become available on the website after the use of data for scientific publication(s).

WP3 Leader: Academisch Ziekenhuis Groningen (UMCG), the Netherlands

WP3 Co-Leader (Tasks 3.1, 3.2): Maastricht University

Implementation and Evaluation of tailored interventions:

  • D4.1: Preparation of the implementation plans including monitoring and evaluation frameworks (1 for each intervention)
    Expected Delivery: Fourth quarter of 2023
  • D4.2: Implementation reports including monitoring/evaluation results (quantitative, qualitative and cost effectiveness), one for each community where the intervention is implemented.
    Expected Delivery: Fourth quarter of 2025
  • D4.3: Overall report presenting key findings from individual implementations.
    Expected Delivery: First quarter of 2026

Some deliverables are initially confidential, but an executive summary will be made available immediately. The deliverable will become available on the website after the use of data for scientific publication(s).

WP3 Leader: Astiki Mikerdoskopiki Etaireia Prolipsis (Prolepsis), Greece

WP4 Co-Leader (Task 4.3.2):Academisch Ziekenhuis Groningen (UMCG), the Netherlands

Guideline development 

  • D 5.1: The creation of guidelines that will be applicable to all EU countries and will enable them to remove health systems barriers to immunisation among underserved communities.

The guidelines will be accompanied by:

  • D 5.2: Action framework applicable to all three levels targeted by the guidelines (national, subnational and facility) to ensure that they are implementable and relevant to the operational level in each country
  • D 5.3: Interactive tool – an online version of the guidelines and action framework

Expected Delivery: First quarter of 2026

Some deliverables are initially confidential, but an executive summary will be made available immediately. The deliverable will become available on the website after the use of data for scientific publication(s).

WP5 Leader:UK Health Security Agency (UKHSA)

Strengthening Education and Knowledge on Immunisation (SEKI)

  • D6.1 Establishment of an online system with up-to-date educational content for healthcare workers and medical students, which presents the possibility to register for educational activities and to collect training points once the platform has passed the testing phase.
    Third quarter of 2023
  • D6.2 Report based on lessons learned in RIVER-EU and exclusive Strengthening Education and Knowledge on Immunisation (SEKI) training materials dedicated to cultural competency working on migrant and minority health, as well as online platform sustainability.

Expected Delivery: Second quarter of 2026

Some deliverables are initially confidential, but an executive summary will be made available immediately. The deliverable will become available on the website after the use of data for scientific publication(s).

WP6 Leader: Vienna Vaccine Safety Initiative (VIVI)

Dissemination and exploitation

  • D7.1 Dissemination and Communication Plan and visual identity, and website launch.
    Expected Delivery: Third quarter of 2021
  • D7.2 A report on the engagement of target groups will be produced in M24, to assess the need for changes in strategy.
    Expected Delivery: Second quarter of 2023
  • D7.3 Exploitation plan.
    Expected Delivery: Second quarter of 2025

Some deliverables are initially confidential, but an executive summary will be made available immediately. The deliverable will become available on the website after the use of data for scientific publication(s).

WP7 Leader: EuroHealthNet

WP7 Co-Lead: Connaxis

RIVER-EU Newsletters

Search